Long-Term Integrated Safety Summary of Ruxolitinib Cream in Phase 3 Clinical Trials of Patients With Vitiligo
media
posted on 2025-10-02, 12:38 authored by Adis journals on behalf of:, David Rosmarin, Amit G. Pandya, Thierry Passeron, Seth B. Forman, Jacek Zdybski, Mark Amster, Christina Feser, Kim A. Papp, Anthony Nuara, Deanna Kornacki, Shaoceng Wei, Haobo Ren, John E. Harris, Khaled Ezzedine<p dir="ltr"><b>Article full text</b></p><p dir="ltr">The above Graphical Plain Language Summary represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, and copyright information, please see the full text online (see “read the peer-reviewed publication” opposite).</p>
History
Related Materials
- 1.
